1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Villar LM, García-Sánchez MI, Costa-Frossard L, Espiño M, Roldán E, Páramo D, Lucas M, Izquierdo G, Álvarez-Cermeño JC.

    Immunological Markers of Optimal Response to Natalizumab in Multiple Sclerosis

    ARCHIVES OF NEUROLOGY . 69(2): 191-197. Nº de citas: 41

    [doi:10.1001/archneurol.2011.971]

  • Magraner MJ, Bosca I, Simó-Castelló M, García-Martí G, Alberich-Bayarri A, Coret F, Alvarez-Cermeño JC, Martí-Bonmatí L, Villar LM, Casanova B.

    Brain atrophy and lesion load are related to CSF lipid-specific IgM oligoclonal bands in clinically isolated syndromes

    Neuroradiology . 54(1): 5-12. Nº de citas: 43

    [doi:10.1007/s00234-011-0841-7]

  • del Campo R, Martínez E, del Fresno C, Alenda R, Gómez-Piña V, Fernández-Ruíz I, Siliceo M, Jurado T, Toledano V, Arnalich F, García-Río F, López-Collazo E.

    Translocated LPS might cause endotoxin tolerance in circulating monocytes of cystic fibrosis patients.

    Plos One . 6(12): . Nº de citas: 29

    [doi:10.1371/journal.pone.0029577]

  • Santón A, Cristóbal E, Aparicio M, Royuela A, Villar LM, Alvarez-Cermeño JC.

    High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL . 17(11): 1295-1300. Nº de citas: 22

    [doi:10.1177/1352458511411063]

  • Abraira V, Alvarez-Cermeño JC, Arroyo R, Cámara C, Casanova B, Cubillo S, de Andrés C, Espejo C, Fernández O, Ferrer J, Figueredo MA, García-Merino A, García-Sánchez MI, García-Trujillo JA, Gómez M, González-Oria C, Gosis A, Izquierdo G, Jímenez J, López-Trascasa M, Montalbán X, Moreno MJ, Muñoz D, Nuñez V, Muriel A, Navarro J, Olascoaga J, Oreja-Guevara C, Prada A, Ramil E, Ramo-Tello C, Rodríguez C, Rodríguez E, Rodríguez-Frías F, Rodríguez-Antigüedad A, Rodríguez-Molina JJ, Ruiz E, Saiz A, Sarasola E, Simó M, Yagüe J, Villar LM.

    Utility of oligoclonal IgG band detection for MS diagnosis in daily clinical practice

    JOURNAL OF IMMUNOLOGICAL METHODS . 371(1-2): 170-173. Nº de citas: 20

    [doi:10.1016/j.jim.2011.06.009]

  • Villar LM, Espiño M, Roldán E, Marín N, Costa-Frossard L, Muriel A, Alvarez-Cermeño JC.

    Increased peripheral blood CD5+B cells predict earlier conversion to MS in high-risk clinically isolated syndromes

    MULTIPLE SCLEROSIS JOURNAL . 17(6): 690-694. Nº de citas: 22

    [doi:10.1177/1352458510396922]

  • Villar LM, Espiño M, Cavanillas ML, Roldán E, Urcelay E, de la Concha EG, Sádaba MC, Arroyo R, González-Porqué P, Alvarez-Cermeño JC.

    Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis

    CLINICAL IMMUNOLOGY . 137(1): 51-59. Nº de citas: 26

    [doi:10.1016/j.clim.2010.06.007]

  • Boscá I, Magraner MJ, Coret F, Alvarez-Cermeño JC, Simó-Castelló M, Villar LM, Casanova B.

    The risk of relapse after a clinically isolated syndrome is related to the pattern of oligoclonal bands

    JOURNAL OF NEUROIMMUNOLOGY . 226(1-2): 143-146. Nº de citas: 30

    [doi:10.1016/j.jneuroim.2010.05.032]

  • Bosca I, Villar LM, Coret F, Magraner MJ, Simó-Castelló M, Alvarez-Cermeño JC, Casanova B.

    Response to interferon in multiple sclerosis is related to lipid-specific oligoclonal IgM bands

    MULTIPLE SCLEROSIS JOURNAL . 16(7): 810-815. Nº de citas: 19

    [doi:10.1177/1352458510371961]

  • Comabella M, Fernández M, Martin R, Rivera-Vallvé S, Borrás E, Chiva C, Julià E, Rovira A, Cantó E, Alvarez-Cermeño JC, Villar LM, Tintoré M, Montalban X.

    Cerebrospinal fluid chitinase 3-like 1 levels are associated with conversion to multiple sclerosis

    Brain . 133(4): 1082-1093. Nº de citas: 188

    [doi:10.1093/brain/awq035]

  • Bridel C, van Wieringen WN, Zetterberg H, Tijms BM, Teunissen CE, and the NFL Group, Alvarez-Cermeño JC, Andreasson U, Axelsson M, Bäckström DC, Bartos A, Bjerke M, Blennow K, Boxer A, Brundin L, Burman J, Christensen T, Fialová L, Forsgren L, Frederiksen JL, Gisslén M, Gray E, Gunnarsson M, Hall S, Hansson O, Herbert MK, Jakobsson J, Jessen-Krut J, Janelidze S, Johannsson G, Jonsson M, Kappos L, Khademi M, Khalil M, Kuhle J, Landén M, Leinonen V, Logroscino G, Lu CH, Lycke J, Magdalinou NK, Malaspina A, Mattsson N, Meeter LH, Mehta SR, Modvig S, Olsson T, Paterson RW, Pérez-Santiago J, Piehl F, Pijnenburg YAL, Pyykkö OT, Ragnarsson O, Rojas JC, Romme Christensen J, Sandberg L, Scherling CS, Schott JM, Sellebjerg FT, Simone IL, Skillbäck T, Stilund M, Sundström P, Svenningsson A, Tortelli R, Tortorella C, Trentini A, Troiano M, Turner MR, van Swieten JC, Vågberg M, Verbeek MM, Villar LM, Visser PJ, Wallin A, Weiss A, Wikkelsø C, Wild EJ.

    Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.

    JAMA NEUROLOGY . : .

    [doi:10.1001/jamaneurol.2019.1534]

  • Pérez-Torre P, López-Sendón JL, Mañanes Barral V, Parees I, Fanjul-Arbós S, Monreal E, Alonso-Canovas A, Martínez Castrillo JC.

    Concomitant treatment with safinamide and antidepressant drugs: Safety data from real clinical practice.

    NEUROLOGIA . : .

    [doi:10.1016/j.nrl.2021.08.004]

  • Cuello JP, Martínez Ginés ML, García Domínguez JM, Tejeda-Velarde A, Lozano Ros A, Higueras Y, Meldaña Rivera A, Goicochea Briceño H, Garcia-Tizon S, de León-Luis J, Medina Heras S, Fernández Velasco JI, Pérez-Pérez S, García-Martínez MÁ, Pardo-Rodríguez B, Domínguez-Mozo MI, García-Calvo E, Estévez H, Luque-García JL, Villar LM, Alvarez-Lafuente R.

    Short-chain fatty acids during pregnancy in multiple sclerosis: A prospective cohort study.

    EUROPEAN JOURNAL OF NEUROLOGY . : .

    [doi:10.1111/ene.15150]

  • Casanova B, Castillo J, Quintanilla-Bordás C, Sanz MT, Fernández-Velasco JI, Alcalá C, Carratalá S, Gasque R, Rubio A, Cubas L, Villar LM, Pérez-Miralles F.

    Oligoclonal M bands unveil occult inflammation in multiple sclerosis.

    MULTIPLE SCLEROSIS AND RELATED DISORDERS . 68: 104118-104118.

    [doi:10.1016/j.msard.2022.104118]

  • Costa-Frossard França L, Meca Lallana V, Labiano-Fontcuberta A, Blasco R, Monreal E, Martínez Ginés ML, Aguirre C, Sabin Muñoz J, Sainz de la Maza S, Cuello JP, Díaz-Pérez C, Chico García JL, Lozano Ros A, Rodríguez Jorge F, Martínez Martínez S, García Domínguez JM.

    Real-World Retrospective Analysis of Alemtuzumab Outcomes in Relapsing-Remitting Multiple Sclerosis: The LEMCAM Study.

    Cns Drugs . : .

    [doi:10.1007/s40263-024-01066-3]